Thu, May 7, 2020
Wed, May 6, 2020
Tue, May 5, 2020

Nathan Weinstein Maintained (ACST) at Strong Buy with Decreased Target to $103 on, May 6th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-103-on-may-6th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Nathan Weinstein of Aegis Capital, Maintained "Acasti Pharma Inc." (ACST) at Strong Buy with Decreased Target from $144 to $103 on, May 6th, 2020.

Nathan has made no other calls on ACST in the last 4 months.



There is 1 other peer that has a rating on ACST. Out of the 1 peers that are also analyzing ACST, all agrees with Nathan's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Mike Crawford of "B. Riley Securities" Downgraded from Strong Buy to Hold and Held Target at $96 on, Monday, January 13th, 2020

Publication Contributing Sources